Scope of the Study
CRISPR technology is a simple yet powerful tool for editing genomes can be used in the COVID-19. This technology allows researchers to easily alter DNA sequences and modify gene function. With the use of this technology kits the coronavirus can be detected in approximately one hour. Recently U.S. Food and Drug Administration (FDA) has approved Sherlock Biosciences Company's Sherlock CRISPR SARS-CoV-2 kit for the detection of the virus that causes COVID-19, providing results in approximately one hour. These kits are designed for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests.
The market study is being classified by Type (Enzymes, Kits, gRNA, Libraries and Design Tools) and major geographies with country level break-up.
Thermo Fisher Scientific (United States), Merck KGaA (Germany), Genscript Biotech (United States), Integrated DNA Technologies, Inc. (United States), Horizon Discovery Group (United Kingdom), Agilent Technologies (United States), Cellecta, Inc. (United States), GeneCopoeia, Inc. (United States), New England Biolabs (United States) and Origene Technologies, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Synthego Corporation (United States) and Toolgen, Inc. (South Korea).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global COVID-19 CRISPR Technology market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global COVID-19 CRISPR Technology market by Type, Application and Region.
On the basis of geography, the market of COVID-19 CRISPR Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Number of Deaths Associated with COVID-19
- Growing Focus on Development of Gene Therapeutics
- High Investments by the Major Players in the Market
- High Demand for Diagnostics Kits for Early Detection of COVID-19
- Increased Government Funding for Research and Development
- High-Cost Associated with CRISPER Technology Test Kits
- Shortages of Kits due to High Demand
- Growing Demand for Diagnostic Kits with Increasing COVID-19 Cases Worldwide
- Increasing Demand for Cure of COVID-19
- Growth in the Health Care Industry
- Stringent Government Rules and Regulations
Key Target AudienceCOVID-19 CRISPR Technology Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase